Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Boston Scientific (NY: BSX )

106.11 -0.03 (-0.03%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Boston Scientific Clocks Strong Q1 Earnings As Elective Surgeries Recover, Boosts FY23 Outlook
Boston Scientific Corp (NYSE: BSX) generated Q1 revenues 
Via Benzinga
Boston Scientific Approaches A Profit-Taking Zone On First-Quarter Beat
The company expects full-year organic sales growth of 8%. 
Via Investor's Business Daily
Nasdaq Futures Surge On Microsoft, Alphabet Earnings Cheer: Analyst Tells Why Investors Might Not 'Sell In May And Go Away'
Stocks could rebound from Tuesday’s steep sell-off, as earnings from Alphabet, Inc. 
Via Benzinga
3 Medtech Companies with Higher Future Share Prices
The analysts see normalization and growth for the med tech industry and have started picking their favorites for 2023 and beyond. 
Via MarketBeat
Analyst Expectations for Boston Scientific's Future
Via Benzinga
Boston Scientific Corp. (NYSE: BSX) Climbs to New 52-Week High
Via Investor Brand Network
Boston Scientific Corp. (NYSE: BSX) Climbs to New 52-Week High
Via Investor Brand Network
Why Shockwave Medical Stock Blasted More Than 10% Higher on Friday
The compay might soon be swallowed by a larger rival. 
Via The Motley Fool
Shockwave Rockets As Boston Scientific Reportedly Mulls A Takeover
The deal would help bolster Boston Scientific's cardiovascular portfolio. 
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Diversified Abbott Laboratories Could Reverse And Move Higher
Abbott Laboratories reported a solid quarter driven by gains in the core business that are accelerating as COVID sales decline. 
Via MarketBeat
Exposures COVID-19
Analyst Expectations for Boston Scientific's Future
Via Benzinga
Boston Scientific Corp. (NYSE: BSX) Climbs to New 52-Week High
Via Investor Brand Network
Looking Into Boston Scientific's Recent Short Interest
Via Benzinga
Healthcare Innovation Drives Medical Device Makers To New Highs
Medical products makers Stryker and Boston Scientific are rallying to all-time highs, while sector peer DexCom is forming a constructive base. 
Via MarketBeat
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
NVIDIA, Boston Scientific And This Technology Stock Insiders Are Selling
The Nasdaq Composite closed higher by over 200 points on Friday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Boston Scientific Corp. (NYSE: BSX) Records 52-Week High Wednesday Morning
Via Investor Brand Network
Can Healthcare Stocks Survive Macro Headwinds?
Healthcare stocks are supposed to be defensive plays in a choppy market. However, over the past 18 months, the XLV is flat and down 6% over one year. 
Via Talk Markets
8 Analysts Have This to Say About Boston Scientific
Via Benzinga
Why Boston Scientific Shares Are Trading Higher Today
Via Benzinga
$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today
Via Benzinga
A Preview Of Boston Scientific's Earnings
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
Via Benzinga
BOSTON SCIENTIFIC INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Boston Scientific Corporation - BSX
From Kahn Swick & Foti, LLC
Via Business Wire
Thermo Fisher Pops On Its Bullish Outlook As Boston Scientific Gains On Its In-Line Report
Thermo Fisher provided a bullish outlook, while Boston Scientific's profit view was short. 
Via Investor's Business Daily
GE Healthcare Technology: Speculating On Dividends
GE Healthcare released a solid report and gave steady guidance that includes ample room in the cash flow for a dividend, should the board choose to pay one. 
Via MarketBeat
BOSTON SCIENTIFIC INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Boston Scientific Corporation - BSX
From Kahn Swick & Foti, LLC
Via Business Wire
Earnings Scheduled For February 1, 2023
Companies Reporting Before The Bell • Novo Nordisk (NYSE:NVO) is expected to report quarterly earnings at $0.85 per share on revenue of $6.84 billion. 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.